The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Now, for the first time, a new group of drugs called monoclonal antibodies have been shown to slow down the decline in thinking and memory in Alzheimer’s patients, the most common form of dementia.

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

Tau proteins help to stabilise the internal skeleton of nerve cells (neurons) in the brain. But in Alzheimer’s disease, these ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...